E Fund Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,236
| Closed | -$235K | – | 435 |
|
|
2024
Q4 | $235K | Buy |
+12,236
| New | +$235K | 0.01% | 345 |
|
|
2024
Q2 | – | Sell |
-19,323
| Closed | -$338K | – | 382 |
|
|
2024
Q1 | $338K | Buy |
19,323
+8,448
| +78% | +$148K | 0.02% | 259 |
|
|
2023
Q4 | $237K | Sell |
10,875
-2,562
| -19% | -$55.8K | 0.02% | 258 |
|
|
2023
Q3 | $206K | Buy |
13,437
+315
| +2% | +$4.83K | 0.02% | 255 |
|
|
2023
Q2 | $312K | Buy |
13,122
+3,078
| +31% | +$73.2K | 0.02% | 214 |
|
|
2023
Q1 | $256K | Buy |
+10,044
| New | +$256K | 0.02% | 260 |
|